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Abstract (Word count 223; Limit is 250 words) 
Objective:  To evaluate gender differences in diabetes self-care components including glycemic, 
blood pressure and lipid control, utilization of diabetes technologies and acute diabetes 
complications in adults with type 1 diabetes.  
Methods: Data from the Type 1 Diabetes Exchange registry were utilized to explore gender 
differences.  A total of 9,481 participants over the age of 18 were included in the analysis, 53% 
were female.  Variables of interest included glycemic control measured by hemoglobin A1c 
(HbA1c), systolic and diastolic blood pressures, presence of dyslipidemia, insulin delivery 
modality, and rates of acute complications.   
Results: Glycemic control was similar in women and men (mean HbA1c in both groups: 
8.1%±1.6% (64±16 mmol/mol), (p=0.54).  More women used insulin pump therapy (66% vs. 
59%, p<0.001) but use of sensor technology was similar (p=0.42).  Women had a higher rate of 
diabetic ketoacidosis (DKA) (5% vs. 3%, p<0.001) and eating disorders (1.7% vs. 0.1%, p 
<0.001).  Rates of severe hypoglycemia were not different between men and women (p=0.42).  
Smoking (6% vs 4%, p<0.001), systolic (125±14.2 vs. 121±14.4, p<0.001) and diastolic blood 
pressure (73.3±9.5 vs. 72.2±9.3, p<0.001) and rate of dyslipidemia (28% vs. 23%, p<0.001) were 
higher in men.  
Conclusion:  While glycemic control in type 1 diabetes was similar regardless of gender, rates of 
DKA and eating disorders were higher in women while rates of smoking, hypertension and 
dyslipidemia were higher in men.    
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1 Introduction 
The influence of gender on morbidity and mortality is being acknowledged for many 
diseases including type 1 diabetes.  At any age, women with type 1 diabetes have a higher risk of 
death, both from any cause and, particularly, from cardiovascular diseases as compared to men 
with type 1 diabetes (1, 2).  Yet, the reasons for excess mortality in women with type 1 diabetes 
are not completely understood.   
Optimal control of blood glucose, blood pressure and lipids are known to reduce the 
cardiovascular risk in patients with type 1 diabetes (3-5).  Few studies have reported gender 
differences in glycemic and lipid control in patients with type 1 diabetes.  Data from the Diabetes 
Follow-up Registry in Germany and Austrian has demonstrated female gender was associated 
with poor glycemic control, elevated body mass index (BMI), total cholesterol, and LDL-
cholesterol (3). Women with type 1 diabetes are also less likely than men to receive 
antihypertensive agents or lipid lowering drugs despite their observed high cardiovascular risk 
(5).  However, these studies did not provide explanations for the gender inequities in poor 
glycemic control. Diabetes self-care related to insulin delivery, frequency of glucose monitoring, 
and lifestyle contribute to glycemic control (6). Similarly, the use of diabetes technologies, such 
as insulin pumps and continuous glucose monitoring systems, have been shown to improve 
glycemic control and reduce acute diabetes complications including diabetic ketoacidosis (DKA) 
and severe hypoglycemia (SH) (7,8).  Yet, it is unknown whether gender differences exist in 
diabetes self-care and the utilization of diabetes technologies.  
Therefore, the present study aimed to examine the gender differences in glycemic, blood 
pressure and lipid control, use of advanced diabetes-management technologies and occurrence of 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
Page 4 of 21 
 
acute diabetes complications in adults with type 1 diabetes from the T1D Exchange (T1DX) 
clinic registry 
2 Research Design and Method 
2.1 Study population: 
The T1DX clinic registry includes more than 30,000 individuals with type 1 diabetes 
followed in a network of over 80 adult and pediatric diabetes clinics across the United States. 
Each clinic received approval from an institutional review board (IRB).  Informed consent was 
obtained according to IRB requirements from adult participants.  Data were collected for the 
clinic registry central database from participants’ medical records and comprehensive 
questionnaire completed by the participant. 
 The present analysis included 9,481 participants aged 18 years or above with most recent 
registry data collection from clinical visits between March 1, 2016 and May 31, 2017.  
Demographic, socioeconomic, and diabetes management characteristics were collected from 
participant self-reported questionnaires as previously described (9).  Participants in the T1DX 
registry identified themselves as men or women; therefore, we have used the term gender 
throughout the text consistent with reporting guidelines (10).  Transgender individuals were 
excluded from study.  Age, diabetes duration, smoking status, previous diagnosis of eating 
disorder, statin use, BMI, blood pressure, lipid profiles, and the most recent HbA1c 
measurement, whether obtained via point-of-care or local laboratory, within three months prior 
to clinic visit were obtained from the clinic medical record.  Frequency of clinic visits was 
defined using number of reported HbA1c measurements in the 15 months prior to the most 
recent clinic exam.  Method of insulin delivery (multiple daily injections [MDI] or use of insulin 
pump), use of a continuous glucose monitor (CGM), and frequency of self-monitored blood 
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glucose (SMBG) levels were collected from medical records.  Occurrences of DKA and SH in 
the 12 months prior to clinic exams were also collected from medical records.  DKA was defined 
as at least one event having hyperglycemia and meeting the following criteria over the prior year: 
1) symptoms such as polyuria, polydipsia, nausea or vomiting; 2) serum ketones or 
large/moderate urine ketones; 3) either arterial blood pH <7.3 or venous pH <7.3 or serum 
bicarbonate <15; and 4) treatment provided in a health care facility.  SH was defined as 
hypoglycemia resulting in seizure or loss of consciousness. High blood pressure was defined as 
systolic blood pressure ≥140 and/or diastolic blood pressure ≥ 90.  Participant-reported data were 
analyzed to assess compliance with prescribed medical regimens based on the frequency of 
missed insulin doses and number of days of physical activity lasting more than 30 minutes.   
2.2 Statistical analysis: 
Demographic and diabetes-related clinic characteristics were tabulated according to 
gender overall and within age group (18-24 years, 25-49 years, >50 years) since diabetes 
management characteristics including glycemic control, lipid profile, blood pressure and 
hypoglycemia are influenced by age (9, 11-13).  Associations between continuous characteristics 
and gender were tested by t-tests or Wilcoxon rank-sum tests, as appropriate.  The relationships 
between categorical characteristics and gender were examined using chi-square tests.  Fisher’s 
exact tests were performed when expected event number was small.  
A linear regression model was used to examine the relationship between HbA1c and 
gender with adjustment for race/ethnicity, duration of diabetes, and insurance status. Gender 
difference in achieving glycemic control target (less than or equal to 53 mmol/mol [7.0%]) was 
assessed using multivariate logistic regression adjusting for the above potential confounders.  
The association between frequency of checking SMBG among non-CGM users and gender was 
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assessed using a linear regression model adjusted for race/ethnicity, diabetes duration, insurance 
status, and use of pump.  Multivariate logistic regression was performed to examine the 
association between use of advanced diabetes technology devices (pump and/or CGM) and 
gender adjusting potential confounders.  A multivariate logistic regression model was also used 
to assess the association between gender and occurrence of at least one SH event.  A similar 
approach was applied to test the gender effect on occurrence of at least one episode of DKA 
events.   
All analyses were completed in overall cohort as well as in each age group (18-24 years 
old, 25-49 years old, and ≥50 years old).  Data analyses were performed using SAS version 9.4 
(2011 SAS Institute Inc., Cary, NC).  Adaptive false discovery rate (aFDR) method was 
performed to adjust for multiple comparisons (14).  All p-values are two-sided.  Criteria for 
statistical significance was based on an alpha of 0.01 due to large sample size and multiple 
comparisons. 
3 Result: 
3.1 Diabetes Self-care and Management 
Of 9,481 adults with type 1 diabetes, 53% were women (n=4,998).  The majority of 
participants (85% women and 86% men) were non-Hispanic White.  Forty-eight percent of 
women and 42% of men reported annual household incomes less than $75,000 while 53% of 
women and 51% of men reported having a bachelor’s degree or higher.  Most participants (79% 
women and 79% men) had private health insurance (Table 1). 
Table 2 provides data regarding the participants’ general health and diabetes self-care 
behaviors based on both gender and age group.  Men with type 1 diabetes were more likely to be 
smokers than women with type 1 diabetes (6% vs. 4%, odds ratio 1.43, 95% CI; 1.19-1.72).  
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Self-reported frequency of exercise was higher in men compared to women (3.8 vs. 3.3 
reported days exercising per week, p<0.001).  While the proportion of overweight and obesity 
was higher among young women (18-24 years; 53% vs. 40%), more middle-aged and older men 
were identified as overweight or obese (Table 2). Both genders reported at least tri-annual visits. 
Of the cohort, 1,321 of MDI users reported frequency of missing basal (long-acting) 
insulin and 4,170 participants (insulin pump and MDI users) reported their frequency of missing 
mealtime bolus insulin. 8% of MDI users reported missing basal insulin more than once a week 
and 20% of adults reported missing at least one mealtime bolus insulin more than once a week. 
However, there was no difference in the frequency of missing basal insulin or mealtime insulin 
between men and women with type 1 diabetes (Table 2).  
 Across all age groups, men had higher systolic blood pressures compared to women 
(mean 125±14.2 in men vs. 121±14.4 in women, p<0.001).  Although diastolic blood pressure 
was also higher in men regardless of age, there was no gender difference in diastolic blood 
pressure in youngest cohort of participants (72.3±8.5 in women vs. 72.1±9.5 in men, p=0.46).  
More men failed to attain goal blood pressures (16% in men vs. 11% in women, p<0.001), 
defined as systolic blood pressure under 140 and/or diastolic blood pressure under 90 mmHg.  
Twenty-eight percent of men had dyslipidemia compared to 23% of women (p<0.001). 
Frequency of dyslipidemia did not differ by gender in young adults; however, after age 25 years, 
a higher proportion of men had dyslipidemia (Table 2).  Use of statin was higher in men with 
type 1 diabetes compared to women with type 1 diabetes (38% vs. 31%, p<0.001).  The clinic-
reported frequency of eating disorders was higher among women across all ages compared to 
men (1.7% vs 0.1%, p<0.001). 
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3.2 Glycemic control, use of diabetes technology, and acute diabetes complications 
There was no difference in glycemic control (assessed by mean HbA1c) between women 
and men ( 8.1% [65 mmol/mol] vs. 8.1% [65 mmol/mol], p=0.54).  The difference in glycemic 
control was non-significant even after adjusting for oral contraceptive use (p=0.68). Similarly, 
there were no gender differences in frequencies of adults achieving targeted HbA1c of <7.0% 
(<53 mmol/mol) between young (11% vs. 13%, p=0.56), middle aged (28% vs. 27%, p=0.21) or 
older adults (26% vs. 29%, p=0.10) with type 1 diabetes (Table 3).  
Women were significantly more likely to report insulin pump use compared to men (66% 
vs. 59%, p<0.001) (Table 3).  As demonstrated in table 3, CGM use was similar between genders 
(29% vs.27%, p=0.42).  Frequency of blood glucose self-monitoring was higher among young 
and middle aged women compared to men, while those over 50 years had similar frequency of 
testing regardless of gender.  There was no gender difference in the frequency of clinic-reported 
SH events (2% in women vs. 2% in men, p=0.42).  However, frequency of at least one episode of 
DKA was higher in women as compared to men (5% vs. 3%, p<0.001) (Table 2). Importantly, 
the frequency of DKA was highest in young women who had a 1.7 fold increase in the frequency 
of DKA as compared to young men.   
4 Discussion 
While previous studies have reported higher mortality in women with type 1 diabetes 
compared to men, the data available from the T1DX registry provided us a unique opportunity to 
analyze over 9,000 adults with type 1 diabetes to understand what clinical, metabolic, and 
therapeutic differences may exist between the genders that could impact the cardiovascular risk 
and mortality. Intriguingly, there was no difference in glycemic control; yet, modifiable risk 
factors for cardiovascular disease including rates of smoking, hypertension, and dyslipidemia 
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were higher in men than women.  Conversely, women were noted to have a higher rate of DKA 
and clinic-reported eating disorders.  
While smoking was higher in men with type 1 diabetes,  the rates of smoking were lower 
in the T1DX registry participants with type 1 diabetes as compared with data from the general 
US population (15).  As smoking in the presence of diabetes is known risk factor for micro- and 
macro-vascular complications (16,17), clinicians should focus on smoking cessation and 
prevention strategies for adults with type 1 diabetes.  
Additionally, BMI is a known cardiovascular risk factor (18) and although no gender 
differences were observed in BMI, a large proportion of study participants had higher than 
recommended BMI levels.  Only 39% of women and 34% of men with type 1 diabetes in the 
T1D Exchange cohort had normal BMIs, which is in line with recent data reporting increasing 
prevalence of overweight and obesity in patients with type 1 diabetes (19).  The prevalence of 
obesity in patients with type 1 diabetes is higher in the US compared to Germany and Austria  
based on data from their DPV registry (20) contributing to challenges in achieving optimal 
glycemic and metabolic control and prevention of cardiovascular diseases.  Despite higher rates 
of obesity (26.1% vs. 25.2%), women with type 1 diabetes reported lower rates of exercise (3.3 
days vs 3.7 days) compared to men with type 1 diabetes.  
In our study, women with type 1 diabetes had higher rates of DKA compared to men that 
could be in part explained by a higher frequency of eating disorders described in the women in 
our cohort.  Studies have reported 2-3 fold higher risks for eating disorders in women with type 1 
diabetes (21).  Eating disorders and omission of insulin have been associated with poor glycemic 
control, higher rates of diabetes-related complications, and a three-fold increase in the risk of 
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mortality (22). It is possible that with the rising obesity epidemic, insulin omission is growing 
and thus clinicians should be screen eating disorder in young women with type 1 diabetes. 
 Our data did not identify gender differences in glycemic control or achieving target 
HbA1c levels but it highlights that the majority of men and women (~70%) continue to struggle 
with achieving targeted glycemia as recommended by the American Diabetes Association.  
While 30 years of follow up in the DCCT and EDIC studies showed associations between 
HbA1c levels and cardiovascular disease risks (23), other studies have reported excess risk for 
cardiovascular disease and mortality from cardiac causes regardless of glycemic control in 
women compared to men with type 1 diabetes (1,2, 24,25).  The findings from these studies 
suggest that glycemic control is an important contributor but not the key risk factor for reducing 
cardiovascular mortality in women with type 1 diabetes. 
Incorporation of technology into the care plan was also assessed and while use of an 
insulin pump was higher in women with type 1 diabetes there were no gender differences in 
utilization of CGM therapy.  Similarly, frequency of clinical visits per year and SMBG were 
higher in women with type 1 diabetes.  Studies have reported improved glycemic outcomes with 
the use of insulin pumps in patients with type 1 diabetes (8,26).  However, in our study, HbA1c 
was not different among women and men with type 1 diabetes despite a higher use of insulin 
pumps among women with type 1 diabetes.  Though CGM use has been shown to improve 
glycemic control and reduce hypoglycemia irrespective of age, gender, education or mode of 
insulin delivery (7,27), only 30% of adults with type 1 diabetes were using a CGM in our cohort.  
The cardio-protection that women in the general population experience compared to men 
is not seen in those living with diabetes (28). However, there are gender differences in 
cardiovascular risk factors in the population living with diabetes. We observed higher mean 
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systolic and diastolic blood pressures and a higher frequency of dyslipidemia in men with type 1 
diabetes.  Similarly, use of lipid lowering medications were higher in men with type 1 diabetes.  
Our findings are in accordance with the Coronary Artery Calcification in Type 1 Diabetes 
(CACTI) study that reported higher LDL and triglyceride levels in men with type 1 diabetes 
compared to women (29).  The CACTI study, examined insulin resistance and insulin resistance-
related factors in asymptomatic adults with and without type 1 diabetes, as well as coronary 
artery calcification (CAC) scores over time. In that study, the presence of type 1 diabetes was 
greatly associated with prevalence of coronary calcification in women compared to men despite 
similar glycemic control and higher lipids detected in men (29).  Studies have reported higher 
HbA1c, BMI Z-scores, atherogenic lipoprotein subfractions, and insulin resistance in adolescent 
girls with type 1 diabetes compared to adolescent boys with the condition (30,31).  Taken 
together, gender differences in glycemic control, BMI, or insulin resistance earlier in life 
(childhood and adolescence) may result in bad metabolic memory and a higher risk for 
cardiovascular diseases in women with type 1 diabetes as they transition to adulthood.  In 
addition, women with type 1 diabetes are at increased risk for hypertensive disorders in 
pregnancy (preeclampsia, gestational hypertension, and others), which further increases the risk 
of cardiovascular disease later in life (32,33). 
Although our study provides important examination of potential modifiable risk factors for both 
glycemic control and clinical care, the data should be interpreted with caution as it is an 
observational study.   Certain outcomes are cross-sectional, such as the use of diabetes 
technologies and SMBG, and thus do not capture the frequency with which patients utilized 
diabetes devices (insulin pumps, CGMs, glucose meters) over time.  In addition, possibility of 
unmeasured confounders on the results of the study cannot be ruled out.  Data were also 
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collected from participant self-reported questionnaires, which are subject to recall bias and 
inaccurate reporting.  On the other hand, participants may have felt more comfortable reporting 
behaviors more truthfully in the anonymized questionnaire as compared to what would be 
divulged to a clinician in the a routine visit.   
While we did not observe differences in glycemic control between men and women with 
type 1 diabetes, our data identified some differences in modifiable parameters.  For men, greater 
focus on eliciting smoking history and counseling on smoking cessation, identification and 
treatment of both hypertension and hyperlipidemia may be critical. While for women, insulin 
dose omission that could potentially be a means to achieve weight maintenance or loss and 
indicate the presence of an eating disorder may be essential.  Furthermore, as insulin omission, 
eating disorders, and risk of DKA are associated, counseling women about the risk of DKA 
should be prioritized.  Future research to elucidate the gender differences leading to greater risk 
for cardiovascular disease remains to be done and will require prospective assessment.  Yet, our 
study lays a framework for factors to be considered.   
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Table 1: Baseline characteristics of Adults with type 1 diabetes by Gender 
 Overall 18-24 years old 25-49 years old ≥50 years old 
 
Women Men Women Men Women Men Women Men 
n=4998 n=4483  n=1661 n=1657  n=1871   n=1482  n=1466 n=1344  
Race/Ethnicity – N (%)         
White Non-Hispanic 4216 (85%) 3846 (86%) 1285 (78%) 1318 (80%) 1585(85%) 1281(88%) 1346 (92%) 1247 (93%) 
Other Race/Ethnicity 768 (15%) 609 (14%) 373 (22%) 335 (20%) 281 (15%) 181 (12%) 114 (8%) 93 (7%) 
Education Level – N (%)         
Less than bachelor's degree  2215 (47%) 2001 (49%) 886 (56%) 882 (57%) 688 (39%) 605 (45%) 641 (47%) 514 (43%) 
Bachelor or higher degree 2495 (53%) 2092 (51%) 690 (44%) 668 (43%) 1085(61%) 742 (55%) 720 (53%) 682 (57%) 
Household Annual Income – 
N (%)  
       
≥$75,000 1875 (52%) 1846 (58%) 579 (53%) 626 (58%) 739 (51%) 617 (55%) 557 (53%) 603 (61%) 
<$75,000 1715 (48%) 1359 (42%) 515 (47%) 452 (42%) 697 (49%) 514 (45%) 503 (47%) 393 (39%) 
Insurance Status – N (%)         
Private Insurance 3782 (79%) 3443 (79%) 1249 (79%) 1272 (80%) 1567(87%) 1259(88%) 966 (68%) 912 (70%) 
Other/No Insurance 1032 (21%) 891 (21%) 334 (21%) 317 (20%) 237 (13%) 175 (12%) 461 (32%) 399 (30% 
T1D Duration (years)  - 
median (IQR) 
18.4 (11.3-30.8) 17.1 (10.4-30.1) 11.3 (8.0-15.0) 10.6 (7.2-14.1) 21.5 (14.7-28.7) 19.9 (13.5-27.5) 36 (22.9-46.5) 35 (23.6-45.7) 
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Table 2: Gender difference in diabetes self-care and management 
  
Overall 18-24 years old 25-49 years old ≥50 years old 
Women 
n=4998 
Men n=4483 
Women 
n=1661 
Men 
n=1657 
Women 
n=1871 
Men 
n=1482 
Women 
n=1466 
Men 
n=1344 
Smoker – N (%) 209 (4%) 261 (6%) 50 (4%) 86 (6%) 95 (5%) 103 (7%) 64 (4%) 72 (5%) 
Days Exercise Per Week - 
Mean±SD 
3.3±2.1 3.8±2.2 3.5±2.1 4.1±2.2 3.1±2.0 3.4±2.0 3.5±2.3 3.7±2.2 
BMI (kg/m2) - Mean±SD 27.5±7.9 27.1±5.9 26.7±8.6 25.3±6.3 28.3±6.5 28.2±5.1 27.5±8.6 28.4±5.6 
BMI – N (%)         
Underweight 63 (1%) 52 (1%) 22 (1%) 42 (3%) 19 (1%) 7 (<1%) 22 (2%) 3 (<1%) 
Normal  1745 (40%) 1514(38%) 707 (45%) 896 (57%) 555 (35%) 347 (27%) 483 (40%) 271 (24%) 
Overweight 1451(33%) 1464(37%) 562 (36%) 411 (26%) 502 (32%) 515 (41%) 387 (32%) 538 (47%) 
Obese 1103(26%) 965 (24%) 269 (17%) 228 (14%) 512 (32%) 401 (32%) 322 (27%) 336 (29%) 
Number of Visits  - Mean±SD 3.3±1.6 3.2±1.6 3.8±1.7 3.6±1.7 3.0±1.6 2.9±1.5 3.2±1.4 3.2±1.5 
Frequency of reported missing 
basal insulin among MDI users – 
N (%)* 
        
Never 395 (60%) 375 (57%) 122 (51%) 96 (41%) 117 (58%) 130 (63%) 156 (71%) 149 (69%) 
Once a month or less 175 (26%) 198 (30%) 68 (28%) 87 (37%) 57 (28%) 58 (28%) 50 (23%) 53 (25%) 
Once a week or less 38 (6%) 48 (7%) 17 (7%) 29 (12%) 13 (6%) 12 (6%) 8 (4%) 7 (3%) 
More than once a week 53 (8%) 39 (6%) 34 (14%) 25 (11%) 14 (7%) 8 (4%) 5 (2%) 6 (3%) 
Frequency of reported missing 
bolus insulin – N (%)† 
        
Never 716 (31%) 591 (32%) 165 (22%) 166 (24%) 272 (31%) 193 (33%) 279 (41%) 232 (40%) 
Once a month or less 751 (33%) 572 (31%) 212 (28%) 184 (26%) 304 (35%) 201 (34%) 235 (34%) 187 (32%) 
Once a week or less 368 (16%) 368 (19%) 146 (19%) 165 (23%) 137 (16%) 96 (16%) 85 (12%) 98 (17%) 
More than once a week 464 (20%) 464 (19%) 229 (30%) 191 (27%) 151 (17%) 99 (17%) 84 (12%) 59 (10%) 
Systolic Blood Pressure - 
Mean±SD 
121 ±14.4 125 ±14.2 118 ±11.3 123 ±11.5 119 ±13.8 125 ±14.6 127 ±16.3 129 ±16.1 
Diastolic Blood Pressure -
Mean±SD 
72.2+9.3 73.3±9.5 72.3±8.5 72.1±9.2 73.8±9.5 76.4±9.0 69.9±9.5 71.3±9.5 
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High Blood Pressure – N (%)** 516 (11%) 688 (16%) 63 (4%) 147 (9%) 167 (9%) 233 (16%) 286 (20%) 308 (23%) 
Dyslipidemia – N (%) 1145(23%) 1249(28%) 96 (6%) 84 (5%) 388 (21%) 410 (28%) 662 (45%) 755 (56%) 
Use of Statin – N (%) 1557(31%) 1722(38%) 75 (5%) 60 (4%) 473 (25%) 605 (41%) 1009(69%) 1057(79%) 
Eating Disorder – N (%) 86 (1.7%) 5 (0.1%) 31 (1.8%) 3 (0.1%) 41 (2%) 0 (0%) 14 (1%) 2 (0.1%) 
*
1,321 of MDI users reported frequency of missing basal insulin  
†4,170 participants reported their frequency of missing mealtime bolus insulin. 
**
High blood pressure is defined as systolic blood pressure ≥140 or diastolic blood pressure ≥90.  Bold represents statistically 
significant (p<0.01) 
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Table 3: Gender differences in glycemic control, adoption of diabetes technologies and acute diabetes complications 
  Overall  18-24 years old 25-49 years old ≥50 years old 
 
Women 
n=4610 
Men n=4064 
Women 
n=1273 
Men 
n=1238 
Women 
n=1871 
Men 
n=1482 
Women 
n=1466 
Men 
n=1344 
HbA1c (mmol/mol) - Mean 
Mean±SD* 
65 ±18 65 ±18 74 ± 20 73 ± 20 62 ± 16 62 ± 16 60 ± 12 59 ± 13 
HbA1c(%) - Mean±SD* 8.1±1.6 8.1±1.6 8.9±1.9 8.8±1.9 7.8±1.4 7.8±1.4 7.7±1.1 7.6±1.2 
HbA1c – N (%)         
<7.0% 992 (21%) 923 (22%) 171 (11%) 202 (13%) 475 (28%) 371 (27%) 346 (26%) 350 (29%) 
≥7.0% 3632(79%) 3218(78%) 1423(89%) 1375(87%) 1222(72%) 980 (73%) 987 (74%) 863 (71%) 
Use of Pump – N (%)† 3255(66%) 2609(59%) 1002 (62%) 946 (58%) 1299(71%) 873 (60%) 954 (66%) 790 (59%) 
Use of CGM – N (%)‡ 1427(29%) 1167(27%) 331 (20%) 285 (18%) 657 (36%) 470 (33%) 439 (31%) 412 (31%) 
Frequency of Self-Monitored 
Blood Glucose among non-CGM 
users - Mean±SD§ 
4.1±2.4 3.8±2.4 3.6±2.3 3.2±2.2 4.2±2.4 3.8±2.3 4.7±2.3 4.6±2.4 
Frequency of Self-Monitored 
Blood Glucose among non-CGM 
users – N (%)§ 
        
<4 times per day 1168(41%) 1228(48%) 548 (54%) 634 (61%) 392 (40%) 367 (49%) 228 (27%) 227 (31%) 
≥4 times per day 1659(59%) 1312(52%) 476 (46%) 408 (39%) 579 (60%) 387 (51%) 604 (73%) 517 (69%) 
Severe Hypoglycemia – N (%)|| 84 (2%) 86 (2%) 13(<1%) 26 (2%) 44(2%) 26(2%) 27 (2%) 34(3%) 
DKA - N (%)|| 221(5%) 116(3%) 116(7%) 67(4%) 73(4%) 29(2%) 32(2%) 20(2%) 
*
 Multivariate analysis adjusting with following potential covariates: race/ethnicity, diabetes duration, and insurance status. 
†Multivariate analysis adjusting with following potential covariates: race/ethnicity, diabetes duration, insurance, CGM use and annual 
household income status. ‡Multivariate analysis adjusting with following potential covariates: race/ethnicity, diabetes duration, 
insurance, pump use and annual household income status. §Multivariate analysis adjusting with following potential covariates: 
race/ethnicity, diabetes duration, insurance, and pump use. 
||
Multivariate analysis adjusting with following potential covariates: 
race/ethnicity, diabetes duration, insurance, pump use, CGM use, frequency of SMBG and annual household income status. Bold 
represents statistically significant (p<0.01) 
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Highlights 
 Highlights the gender differences in diabetes self-care and acute complications among 
US adults with type 1 diabetes 
 Future research is necessary to close the gender gap in diabetes care 
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